Introduction
============

Low back pain is a major social and economic burden on the population, resulting in billions of dollars in payments yearly in the United States alone and affecting 15% to 45% of the population annually \[[@B1][@B2][@B3]\]. There is a substantial number of new diagnoses of back pain yearly and 1% to 2% of the United States adult population is disabled secondary to back pain yearly \[[@B4][@B5][@B6]\]. The estimated total cost of direct medical expenditures in the United States for spine care and related disabilities from spinal pathology in 2006 was more than \$85 billion and the data suggest the use and cost of spine care have continued to increase in recent years \[[@B4][@B5][@B6][@B7][@B8]\]. Although the etiology of low back pain remains multifactorial, degenerative changes in the intervertebral discs of the spine have been strongly associated with the onset of pain \[[@B1][@B9][@B10][@B11]\].

The World Health Organization defines obesity as a body mass index (BMI) of 30 or above \[[@B12]\]. Obesity is a serious public health problem worldwide and its prevalence is rapidly increasing \[[@B7]\]. Obesity has been shown to increase the risks of cardiovascular disease, diabetes, osteoarthritis, and spine disease \[[@B13][@B14][@B15]\]. Obesity has been implicated as a risk factor of lumbar disc degeneration, but previous epidemiological studies have conflicting associations \[[@B16]\].

Diabetes mellitus (DM) is a chronic condition associated with high blood glucose levels resulting from insulin secretory defects and insulin resistance. Elevated glucose concentrations have been associated with an increased risk of disc degeneration by directly influencing disc cell proliferation and survival \[[@B17][@B18][@B19]\].

More than one-third of the population of industrialized countries smoke and in the United States, over 20% of the adult population admits to smoking \[[@B20]\]. Highly publicized are the respiratory and cardiovascular effects of tobacco use, but smoking can cause many orthopaedic issues, including delayed fracture-healing, decreased bone density, risk of nonunion of fractures and spinal fusions, as well as delayed or poor wound healing \[[@B21][@B22][@B23]\].

Intervertebral disc degeneration involves an imbalance in anabolic and catabolic activity within the annulus fibrosus and nucleus pulposus cells \[[@B24][@B25][@B26][@B27][@B28]\]. Many factors influence the extracellular environment around intervertebral disc cells including nutrient levels, mechanical loading, and the chemical environment. Alteration in disc cellular viability and activity influences the ability of annulus fibrosus and nucleus pulposus cells to produce extracellular matrix components and maintain tissue health \[[@B26]\].

There have been several studies correlating degenerative disc disease to cigarette smoking, obesity or diabetes on a microscopic level, but no population level study evaluating their effect both independently and synergistically.

Materials and Methods
=====================

Within the PearlDiver Patient Record Database (PearlDiver Technologies Inc., Warsaw, IN, USA; <http://www.pearldiverinc.com/>), International Classification of Diseases, ninth edition (ICD-9) insurance billing codes were used to identify the annual trends of patients diagnosed with lumbar disc degeneration with and without concurrent diagnoses of obesity, diabetes, or tobacco use. We queried the subset of patients within the database that is covered by Humana (Humana Inc., Louisville, KY, USA; <https://www.humana.com/>), a private health insurance company that covers nearly 20 million patients across the United States.

Codes ICD-9-D-722.73 and ICD-9-D-722.52 were used to identify the number of patients diagnosed with lumbar disc degenerative disease, with or without myelopathy. The lumbar disc degenerative disease population was then split into two cohorts: those with concurrent diagnoses of tobacco use, diabetes, and/or obesity, and those without those diagnoses. To identify patients diagnosed as having a tobacco use disorder, ICD-9-D-V15.82, was used. Patients who were diagnosed with obesity and morbid obesity were identified with the codes ICD-9-D-278.00 and ICD-9-D-278.01 and analyzed collectively in a group of patients referred to throughout this study simply as obese. Finally, patients diagnosed with type 1 or type 2 diabetes, controlled or uncontrolled, were identified with codes ICD-9-D-250.00, ICD-9-D-250.01, ICD-9-D-250.02, and ICD-9-D-250.03. These patients were also analyzed collectively, in a group of patients considered throughout this paper simply as diabetic.

To qualify to be included in the group "lumbar disc degenerative disease+obesity," for example, patients must have been diagnosed as obese on the same record as their disc degenerative disease diagnosis. To qualify to be included in the group "lumbar disc degenerative disease, non-obese," patients could never have been diagnosed as obese throughout the entire span of the database. For groups in which patients had multiple concurrent diagnoses, such as obesity and diabetes, both of those diagnoses similarly had to occur on the same record as the lumbar disc degenerative disease diagnosis. Patients can never have been diagnosed with either to qualify to be included in the analog "non-obese, non-diabetic" group.

For each of the patient populations described above, we tracked the total number of patients who were diagnosed with each code from the beginning of 2007 until the end of 2014. We compared the trends over time between patients with and without concurrent diagnoses of tobacco use, diabetes, or obesity using chi-squared analysis and linear regression. Significance was set at a *p*-value less than 0.05. Demographic information including gender, region, race, and age was collected and analyzed as well.

This retrospective cohort study was deemed exempt from Institutional Review Board review as all patient information was de-identified.

Results
=======

From 2007 until 2014, the number of people within the Humana database diagnosed with lumbar disc degenerative disease rose 241.1%, from 82,129 to 280,399. When adjusted for the growth of population within the database, the prevalence per 10,000 patients increased 130.3%, from 128.63 in 2007 to 296.27 in 2014. The prevalence of males and females diagnosed with lumbar disc degenerative disease was roughly equivalent from 2007 until the first quarter of 2015.

Between patients diagnosed as obese, diabetic, or as smokers, smokers were the least prevalent within the database. However, smokers increased in prevalence more than any of the other populations from 2007 through 2014, having risen 381.7% from 59.39 to 286.15. The most populous age group in this population was between 70 and 74 years old.

Patients diagnosed as diabetic were the most prevalent but increased in prevalence the least, having risen 81.1% from 567.78 to 1,028.01 patients per 10,000 from 2007 through 2014. The prevalence of obese patients rose 214.1%, from 157.76 to 495.53. For both of these populations, the most populous age group was 60--64 years old.

The number of patients diagnosed with the different possible combinations of two of the above three conditions also rose measurably between 2007 and 2014. The prevalence of patients diagnosed with both smoking and obesity on the same record were the least prevalent combination but increased the most, from 3.66 in 2007 to 25.67 in 2014---a 601.1% increase. The prevalence of patients diagnosed with both obesity and diabetes on the same record were the most prevalent but increased in prevalence the least, from 46.09 in 2007 to 135.94 in 2014---a 195.0% increase. The prevalence of patients diagnosed with both smoking and diabetes on the same record rose 377.2%, from 10.67 out of 10,000 patients in 2007 to 50.92 in 2014.

The raw total number of each of these patient groups increased markedly as well, and these results are summarized in \[[Table 1](#T1){ref-type="table"}.

Of those patients diagnosed with lumbar disc degenerative disease, two cohorts of patients were analyzed: those with a concurrent diagnosis of smoking, diabetes, and/or obesity, and those without a concurrent diagnosis (or collection of diagnoses). In every case, patient populations with concurrent diagnoses increased in total number and in prevalence significantly more than patient populations without those diagnoses from 2007 through 2014.

Patients diagnosed with obesity at the same time as their disc degenerative disease diagnosis rose significantly more between 2007 and 2014 than did patients who never were diagnosed as obese (*p*\<0.05). The prevalence of patients diagnosed with obesity and lumbar disc degenerative disease rose 517.9%, from 1.22 to 7.54 out of 10,000 patients ([Fig. 1](#F1){ref-type="fig"}). This increase was nearly five times the increase of patients not diagnosed with obesity, whose prevalence per 10,000 patients rose 108.0%, from 100.16 in 2007 to 208.37 in 2014.

Patients diagnosed as having a tobacco use disorder at the same time as their disc degenerative disease diagnosis also rose significantly more between 2007 and 2014 than patients who were never diagnosed as smokers (*p*\<0.05). The prevalence of patients with disc degenerative disease who were also smokers rose 627.2% from 2007 to 2014 (from 0.40 to 2.88 out of 10,000) compared to just 117.6% (108.12 to 235.25) for the population never diagnosed with smoking ([Fig. 2](#F2){ref-type="fig"}).

Furthermore, the subset of patients diagnosed with lumbar disc degenerative disease and diabetes increased significantly more than patients diagnosed as having lumbar disc degenerative disease but no diabetes (*p*\<0.05). The prevalence of patients with a lumbar disc degenerative disease diagnosis but no diabetes diagnoses rose 126.2% from 80.32 in 2007 to 181.67 in 2014, while the number of patients with a concurrent diabetes diagnoses rose 306.4%, from 3.67 to 14.91 out of 10,000, nearly a three-fold difference ([Fig. 3](#F3){ref-type="fig"}). Gender appeared to make no significant difference on the increase in prevalence among the diabetic and non-diabetic patients diagnosed with lumbar disc degenerative disease.

Chi-squared analysis revealed that patients diagnosed with lumbar disc degenerative disease and smoking on the same record increased significantly more than the number of patients diagnosed with lumbar disc degenerative disease and either obesity or diabetes (*p*\<0.05). Patients diagnosed with lumbar disc degenerative disease and obesity increased significantly more than the number of patients diagnosed with lumbar disc degenerative disease and diabetes (*p*\<0.05).

The data also demonstrates that lumbar disc degenerative disease patients with a combination of comorbid diagnoses increased significantly more from 2007 through 2014 than patients without either of the comorbid diagnoses. The largest increase in prevalence was seen in the patient group diagnosed with lumbar disc degenerative disease, obesity, and smoking all within the same patient record. The prevalence of this population increased 519.8% from 0.05 patients per 10,000 in 2007 to 0.31 in 2014 ([Fig. 4](#F4){ref-type="fig"}). The prevalence of patients diagnosed with lumbar disc degenerative disease, diabetes, and smoking rose 407.7%, from 0.06 to 0.32 patients per 10,000 in the database ([Fig. 5](#F5){ref-type="fig"}). Finally, the number of patients diagnosed with lumbar disc degenerative disease, obesity, and diabetes, increased in prevalence by 374.4%, from 0.25 to 1.20 ([Fig. 6](#F6){ref-type="fig"}).

The number of patients diagnosed with lumbar disc degenerative disease, obesity and smoking increased more than patients diagnosed with lumbar disc degenerative disease and diabetes (*p*\<0.05). Interestingly, the number of patients diagnosed with lumbar disc degenerative disease, obesity and diabetes increased at a slower rate than patients diagnosed with lumbar disc degenerative disease and obesity (*p*\<0.05) alone. More, the number of patients diagnosed with lumbar disc degenerative disease, smoking, and diabetes increased less than the number patients diagnosed with lumbar disc degenerative disease and smoking alone (*p*\<0.05). This all suggests that diabetes had the least significant effect on the increased prevalence rate.

There were 8,683,726 males in the database and 11,225,017 females in the database. Even after adjusting for the difference between males and females in the database, more females were diagnosed with lumbar degenerative disc disease per every 10,000 males, there were 440.5 patients with lumbar disc degenerative disease and per every 10,000 females, there were 474.4 patients with lumbar disc degenerative disease. Similar trends were true among obese patients with lumbar disc degeneration (females 11.5 to males 8.9 per 10,000). However, the opposite trend was true among smokers and diabetic patients, for whom males were more frequent than females. For diabetic patients, the difference was minimal (females 22.7% to males 24.6 per 10,000), and for smokers, the difference was most pronounced (females 3.4 to males 4.9 per 10,000).

Ages 65--69 were the most populous cohort of patients with lumbar disc degenerative disease (203,660), but after adjusting for the number of patients in each age range within the entire database, ages 60--64 were the most frequent per 10,000 patients in that age range, followed by age 55--59, then 65--69. After adjusting for database demographics, patients aged 60--64 were the most frequently diagnosed with smoking, obesity, or diabetes with lumbar disc degenerative disease.

The database consists of many more patients in the South than any other region in the United States (Northeast, Midwest, or West), but even after adjusting for the number of patients in each region in the database, patients from the South were most frequently diagnosed with lumbar disc degenerative disease (533.7/10,000) and patients from the Northwest were diagnosed the least (136.0/10,000). Patients from the Northeast were most frequently diagnosed with smoking and disc degenerative disease (4.44/10,000), followed closely by the South (4.38/10,000). Patients from the South were most frequently diagnosed with smoking or diabetes and lumbar disc degenerative disease.

Discussion
==========

Given the significant socioeconomic burden of lower back pain on the population and its strong association with intervertebral disc degeneration and disease, there remains considerable interest in identifying factors associated with the development of this degenerative process \[[@B1][@B9][@B10][@B11]\]. Previous studies have attempted to analyze the link between lower back pain and various comorbid conditions, including smoking \[[@B29][@B30][@B31]\], obesity \[[@B32][@B33]\], and DM \[[@B17][@B18]\]. These reports range from biomechanical studies to systematic reviews of the literature. Several larger scale studies have attempted to investigate "lower back pain" as opposed to the specific diagnosis of "lumbar disc degeneration." To our knowledge, this is the first report to analyze the relationship between smoking, diabetes and obesity, both independently and synergistically, and the development of lumbar disc degenerative disease at the epidemiologic level. By inclusion of a very large database of almost 20 million patients, we aimed to avoid limitations of previous studies, including low study power and the inherent variability in data collection associated with systematic review of literature.

Though the exact pathophysiology of disc degeneration continues to be investigated, it has been demonstrated that the health of the intervertebral disc is maintained by a complex balance of anabolic and catabolic activity within cells of the annulus fibrosis and nucleus pulposus \[[@B24][@B25][@B26][@B27][@B28]\]. There currently exist two primary theories regarding the mechanism with which tobacco use may contribute to intervertebral disc degeneration. The primary proposed mechanism involves malnutrition of the disc caused primarily by tobacco-related anoxia and vascular disease. Malnutrition of the disc has previously been shown to be strongly associated with disc degeneration \[[@B31][@B34]\] and vascular disruption of this nutritional supply is thought to play a key role \[[@B35][@B36][@B37][@B38]\]. Animal studies have demonstrated a reduction in vertebral body blood flow after administration of nicotine \[[@B37][@B38][@B39]\]. The increased blood concentration of carbon monoxide in smokers results in a decreased oxygen-carrying capacity of hemoglobin and this likely represents a further insult to the intervertebral disc\'s nutritional pathway \[[@B40][@B41]\].

Alternatively, it has been proposed that chemical compounds found in cigarette smoke may directly affect cell viability and activity in the intervertebral disc \[[@B42][@B43]\]. At the microscopic level, human intervertebral disc cells exposed to tobacco smoke demonstrate significant morphologic changes that appear to be dose-dependent \[[@B44]\]. Beyond these structural changes, exposure to cigarette smoke has been shown to increase cell production of interleukin 1β, leading to the upregulation of matrix-degrading metalloproteinases \[[@B26][@B45][@B46]\]. While debate continues regarding the exact mechanism of tobacco-related disc degeneration, evidence suggests a common end result. Gross examination of intervertebral disc tissue exposed to cigarette smoke demonstrates necrosis and fibrosis involving the nucleus pulposus and alteration in the layered composition of the annulus fibrosis \[[@B38][@B47]\].

Several reports have demonstrated an association between smoking and disc degeneration using secondary markers, such as radiographic findings or eventual surgical intervention. Utilizing magnetic resonance imaging (MRI), Battie et al. \[[@B29]\] compared the lumbar disc health of twenty pairs of identical twins discordant for tobacco exposure. With respect to disc height and intensity, the authors reported 18% greater mean disc degeneration scores in the smoking group. Of note, these findings were consistent throughout the lumbar spine, indicating a systemic effect and decreasing the likelihood of a physical loading-related confounding variable. After comparing the smoking history of 205 patients that underwent surgical intervention of cervical or lumbar disc disease with an age and sex-matched control population, An et al. \[[@B30]\] reported a significantly greater rate of tobacco use in both the cervical and lumbar disease group. More recently, Mattila et al. \[[@B31]\] reported on a prospective, 11-year follow-up of more than 57,000 adolescents in an attempt to identify risk factors for lumbar discectomy in this young and relatively healthy population. The authors concluded that, with regards to male subjects, daily smoking was the strongest risk factor for lumbar discectomy \[[@B31]\].

However, not all studies have found a significant correlation between smoking and the development of disc degenerative disease. Gore at al. \[[@B48]\] compared lateral cervical radiographs of 50 smokers and 50 non-smokers. The study failed to find a statistically significant difference in degeneration rates, but the authors admit that plain radiography is not the ideal imaging modality to evaluate disc degeneration. After systematic review of 38 epidemiologic studies, Goldberg et al. \[[@B49]\] concluded that while there exists strong support for the association between smoking and non-specific back pain, too few studies have been performed to confidently link smoking with the other studied end points, such as disc degeneration, herniation, and sciatica. These reports emphasize the difficulty in drawing association, let alone causation, in the setting of numerous confounding variables.

Our findings suggest a strong correlation between lumbar disc degenerative disease and tobacco use. The prevalence of lumbar disc degenerative disease in smokers rose 627.2%, representing a nearly 6-fold increase compared to the non-smoking population.

Our results support a link between lumbar disc degenerative disease and obesity. The prevalence of patients with both lumbar DDD and obesity increased more than 5 times greater than the prevalence of patients with disc degenerative disease without obesity. The prevalence of obesity is high, exceeding 30% in the United States, and remains a major public health issue \[[@B50]\]. "Damaging loading," perhaps similar to that seen in overweight and obese individuals, has been shown to affect intervertebral cell viability, synthesis and matrix remodeling \[[@B51]\]. Excessive biomechanical loading, as a result of both heavy lifting and obesity, has been linked to disc disease and herniation \[[@B52][@B53][@B54][@B55]\]. Obesity has been referred to as some authors as a systemic inflammatory condition, resulting in increased inflammatory markers and the development of atherosclerosis \[[@B56][@B57]\]. This could conceivably represent a vascular insult to the intervertebral disc. Early reports, based on plain film findings, suggested a possible association between increased BMI and lumbar degeneration \[[@B58]\]. More recently, Samartzis et al. \[[@B59]\] reviewed lumbar MR studies of more than 2,500 individuals and reported a significant association between the presence, extent and severity of disc degenerative changes and increasing body weight. Furthermore, obesity may serve as predictor for hospitalization secondary to disc disorders \[[@B60]\]. Takatalo et al. \[[@B61]\] reported an association between abdominal obesity and disc degeneration in 21-year-old males, suggesting a more rapid effect than previously thought. However, the exact mechanism with which obesity may correlate with disc degeneration is poorly understood and other reports have failed to independently correlate obesity with disc degeneration and disease \[[@B33]\].

Previous studies have suggested that diabetes may negatively affect intervertebral disc health. The accumulation of advanced glycation end products in critical disc proteins, such as aggrecan and collagen, results in abnormal turnover and increasing non-enzymatic cross-linking \[[@B62]\]. Metz et al. \[[@B63]\] revealed a strikingly increased rate of tissue cross-linking in the intervertebral discs of rats with increased glycated hemoglobin (HgbA1c) compared to a healthy control group. Increased cross-linking leads to increased stiffness and brittleness, resulting in an intervertebral disc that is may be more susceptible to mechanical damage \[[@B64][@B65]\]. The well-reported microangiopathy associated with diabetes likely further diminishes the flow of nutrients to the already tenuously supplied intervertebral disc \[[@B66]\]. Sakellaridis \[[@B18]\] reported a significantly higher rate of diabetes in patients undergoing lumbar discectomy compared to patients undergoing elective, non-spine related interventions. Furthermore, diabetic patients have been shown to have significantly decreased disc height, in comparison to their non-diabetic counterparts \[[@B67]\]. These findings suggest important clinical implications of molecular-level changes seen in the diabetic intervertebral disc.

Each co-morbidity was found to have a correlation with an increased likelihood for a diagnosis of degenerative disc disease, but smoking and obesity were found to have a synergistic effect on the likelihood of degenerative disc disease. Videman et al. \[[@B55]\] discovered the combination of higher occupational lifting and more smoking during follow-up were predictors of increased disc height reduction in a longitudinal study assessing quantitative MRI measures of disc degeneration in middle-aged 134 monozygotic male twins. Leboeuf-Yde et al. \[[@B33]\] evaluated the association of self-reported physical hard labor, smoking and obesity in four hundred and twelve 40-year old Danes with MRI findings, back pain and a vertebral inflammatory process. They found that there were no significant associations between the single variables and intervertebral disc degeneration. However, they did find that hard physical labor in combination with either heavy smoking or obesity was strongly associated with a vertebral inflammatory process \[[@B33]\].

Limitations of our study include those of any database study. There is a possibility of coding bias due to the somewhat ambiguous nature of Current Procedural Terminology coding. It is also difficult to know if physicians were coding appropriately for lumbar degenerative disc disease at the time of the office visit or if the disease had been present prior to coding for some time and thus correlation with any of the comorbidities may be miscalculated. With regards to the limitations of the database used, we obtained data from a large private insurer (Humana) with customers nationwide, but no other insurers, and the Humana patient population may be distinct from other insurer\'s populations or the uninsured.

Conclusions
===========

This study confirms, on a large scale patient population model, that diabetes, obesity and cigarette smoking each are significantly associated with an increased diagnosis of lumbar degenerative disc disease. Previous literature had found that correlation on a smaller population level and only individually among the comorbidities. This study also discovered that the combination of these morbidities either in different pairings or all three had a synergistic effect on increased rates of lumbar degenerative disc disease. Smoking and obesity, above all, had the highest impact and most dramatic synergistic effect leading to increased rates of lumbar degenerative disc disease. Future studies will need to correlate these risk factors further and potentially will involve prospective studies. Nevertheless, this study is a lead in to support the idea of patient education and preventative care as having a potential impact in prevention of degenerative disc disease within the general population.
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